Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38345
CAS Number:
34661-75-1
Urapidil
Purity:
≥ 95 % (HPLC)
Synonym(s):
6-[[3-[4-(2-Metoxifenil)-1-piperazinil]propil]amino]-1,3-dimetiluracilo
Documents
$154.93 /1G
Tamaño
Request Bulk Quote
Información del producto

Urapidil is a potent antihypertensive agent primarily used in the management of high blood pressure. This compound acts as an alpha-1 adrenergic antagonist and a serotonin receptor agonist, making it effective in reducing vascular resistance and promoting vasodilation. Its unique mechanism of action allows for a rapid decrease in blood pressure without significantly affecting heart rate, making it a preferred choice in acute settings. Urapidil is particularly beneficial in treating hypertensive emergencies and is often utilized in hospital settings for its quick onset of action and favorable safety profile.

In addition to its primary use in hypertension, Urapidil has shown promise in research related to cardiovascular health and may have applications in treating conditions such as anxiety and depression due to its serotonergic activity. Its versatility and effectiveness make it a valuable compound for both clinical and research applications, providing healthcare professionals with a reliable option for managing complex patient needs.

Número CAS
34661-75-1
Fórmula molecular
C20H29N5O3
Peso molecular
387.48
Número MDL
MFCD00133908
Punto de fusión
156 - 161 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
34661-75-1
Fórmula molecular
C20H29N5O3
Peso molecular
387.48
Número MDL
MFCD00133908
Punto de fusión
156 - 161 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Urapidil is widely utilized in research focused on:

  • Hypertension Treatment: Urapidil is primarily used in the management of high blood pressure, offering a unique mechanism of action that combines alpha-1 adrenergic receptor antagonism and central action, making it effective for patients who may not respond to traditional therapies.
  • Cardiovascular Research: In clinical studies, Urapidil is often investigated for its effects on heart rate and vascular resistance, providing valuable insights into cardiovascular health and treatment strategies.
  • Postoperative Care: Its ability to lower blood pressure without causing reflex tachycardia makes Urapidil a preferred choice in postoperative settings, ensuring stable hemodynamics in patients recovering from surgery.
  • Neuroprotective Studies: Emerging research suggests potential neuroprotective effects of Urapidil, making it a candidate for studies aimed at understanding its role in neurodegenerative diseases.
  • Combination Therapies: Urapidil is often explored in combination with other antihypertensive agents, providing a synergistic effect that enhances overall treatment efficacy while minimizing side effects.

Citas